The CMS Administrator’s job is one of the most important and challenging jobs in health care. It is my greatest hope that the ...

With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.

Community health needs assessments identify key health needs and issues, but historically have not included sufficient data ...

The Centers for Medicare and Medicaid (CMS) recently announced the Guiding an Improved Dementia Experience (GUIDE) Model, a voluntary test program designed to benefit people living with dementia ...

The 2023 national health care spending study's authors, who are with the Centers for Medicare and Medicaid Services' Office of the Actuary, discussed the CMS data with members of the news media. The ...

Under the current Medicare Advantage (MA) risk-adjustment system, plans are incentivized to report diagnosis codes on enrollees’ medical claims reflecting additional and more severe health conditions ...

Black and Hispanic patients who receive care from Black and Hispanic physicians have greater use of preventive care. However, receiving care from racially concordant physicians requires that such ...

This article is the latest in the Health Affairs Forefront major series, Medicare and Medicaid Integration. The series features analysis, proposals, and commentary that will inform policies on the ...

Health care spending in the US reached $4.9 trillion and increased 7.5 percent in 2023, growing from a rate of 4.6 percent in 2022. In 2023, the insured share of the population reached 92.5 ...

The Food and Drug Administration (FDA) Breakthrough Devices Program was created by the Congress in the 21st Century Cures Act of 2016. The program is designed to accelerate the development ...

Post-approval research on existing medicines has improved patient outcomes and addressed unmet medical needs. In oncology, post-approval improvements to drugs reflect indications for additional ...